Pacific Biosciences of California, Inc. (PACB) Net margin 2016–2025
Pacific Biosciences of California, Inc. (PACB) net profit margin by fiscal year — reported net income divided by reported revenue.
-341.5%FY2025 · since FY2016: -82.0% → -341.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -341.5% | -140.3 pp |
| FY2024 | -201.2% | -48.3 pp |
| FY2023 | -153.0% | +91.9 pp |
| FY2022 | -244.9% | -106.1 pp |
| FY2021 | -138.8% | -176.1 pp |
| FY2020 | 37.3% | +129.8 pp |
| FY2019 | -92.6% | +37.9 pp |
| FY2018 | -130.4% | -31.8 pp |
| FY2017 | -98.6% | -16.6 pp |
| FY2016 | -82.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice